| Dr Domenic Michael Terenzi, MD | |
|
8001 E 11th Ave Unit 5210, Denver, CO 80220 | |
| (248) 918-9866 | |
| Not Available |
| Full Name | Dr Domenic Michael Terenzi |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 8001 E 11th Ave Unit 5210, Denver, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124414081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | DR0060917 (Colorado) | Primary |
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and share vision and plans on the future generation progressive lenses.
A team of scientists from Australia challenges the findings of a recent study by Wilk et al. demonstrating that plasmablasts transdifferentiate into developing neutrophils in severe coronavirus disease 2019 (COVID-19). The Australian study is currently available on the bioRxiv preprint server.
› Verified 2 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and share vision and plans on the future generation progressive lenses.
A team of scientists from Australia challenges the findings of a recent study by Wilk et al. demonstrating that plasmablasts transdifferentiate into developing neutrophils in severe coronavirus disease 2019 (COVID-19). The Australian study is currently available on the bioRxiv preprint server.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Domenic Michael Terenzi, MD 8001 E 11th Ave Unit 5210, Denver, CO 80220-3392 Ph: (248) 918-9866 | Dr Domenic Michael Terenzi, MD 8001 E 11th Ave Unit 5210, Denver, CO 80220 Ph: (248) 918-9866 |
News Archive
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and share vision and plans on the future generation progressive lenses.
A team of scientists from Australia challenges the findings of a recent study by Wilk et al. demonstrating that plasmablasts transdifferentiate into developing neutrophils in severe coronavirus disease 2019 (COVID-19). The Australian study is currently available on the bioRxiv preprint server.
› Verified 2 days ago
Dr. David Morris Jackson, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 835 E 18th Ave Ste 110, Denver, CO 80218 Phone: 303-825-4646 Fax: 303-825-3215 | |
Laura Dingle, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 835 E 18th Ave Ste 110, Denver, CO 80218 Phone: 303-825-4646 Fax: 303-825-3215 | |
Christina Anne Sass, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1375 E 19th Ave, Denver, CO 80218 Phone: 303-812-6410 | |
Megan Sturdy, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1400 Jackson St, Denver, CO 80206 Phone: 303-388-4461 Fax: 303-270-2174 | |
Dr. Elissa Anne Rosen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7000 E Hampden Ave Ste 200, Denver, CO 80224 Phone: 303-925-4960 Fax: 303-925-4661 | |
Elizabeth Jo Gillespie, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 660 Bannock St, 4th Floor Mc 4000, Denver, CO 80204 Phone: 303-602-5011 Fax: 303-602-5056 | |
Dr. Bree Anne Ashdown, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1960 N Ogden St Ste 400, Denver, CO 80218 Phone: 303-318-1570 |